Table 2.
Azaaurone compounds studied and their observed and predicted antimalarial activities.
| Compounds | R | IC50(μM) | pIC50(obs) | pIC50(pred) | Residual |
|---|---|---|---|---|---|
| 15 | 4′-Br | 49.8 | 4.303 | 4.444 | -0.141 |
| 16 | 4′-Cl | 17 | 4.770 | 4.538 | 0.232 |
| 17a | 2′-Cl | 9.9 | 5.004 | 5.086 | -0.082 |
| 18 | 2′,5′-Cl | 8.4 | 5.076 | 5.049 | 0.0267 |
| 19 | 2′-Cl, 6′-F | 9 | 5.046 | 4.937 | 0.109 |
| 20 | 4′-Et | 1 | 6 | 5.841 | 0.159 |
| 21 | 2′-Et | 12.8 | 5.893 | 5.635 | 0.258 |
| 22 | 2′,6′-Me | 9.1 | 5.041 | 5.549 | -0.508 |
| 23a | 2′,4′-Me | 3.6 | 5.444 | 5.515 | -0.071 |
| 24 | 2′,4′,5′-Me | 5.6 | 5.252 | 5.174 | 0.078 |
| 25 | 2′,3′,5′,6′-Me | 8.9 | 5.051 | 5.147 | -0.096 |
| 26 | 4′-i-Pr | 4.4 | 5.356 | 5.383 | -0.027 |
| 27a | 4′-t-Bu | 7.2 | 5.143 | 5.214 | -0.071 |
| 28 | 4′-Bu | 4.1 | 5.387 | 5.381 | 0.006 |
| 29a | 4′-CCH | 13.4 | 4.873 | 5.489 | -0.616 |
| 30 | 2′,4′-OMe | 5 | 5.301 | 5.349 | -0.048 |
| 31a | 2′,4′,6′-OMe | 1.9 | 5.721 | 5.449 | 0.272 |
| 32 | 3′,4′,5′-OMe | 1.9 | 5.721 | 5.81 | -0.0889 |
| 33 | 4′-SMe | 6.7 | 5.174 | 5.204 | -0.03 |
| 34 | 4′-Morpholino | 8.9 | 5.051 | 5.108 | -0.057 |
| 35a | 4′-N (Me)2 | 3.7 | 5.432 | 5.115 | 0.317 |
Compounds in the test set.